Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01116882 · ClinicalTrials.gov registry record · NA
Percutaneous Coronary Intervention (PCI) Outcomes in Community Versus Tertiary Settings
A NA study, sponsored by Baim Institute for Clinical Research.
- Completed
- Registry status
- NA
- Development phase
- 3,691
- Enrollment target
NCT01116882: Completed NA study, sponsored by Baim Institute for Clinical Research.
NCT01116882 is a NA study that has completed, run by Baim Institute for Clinical Research. The registered enrollment target is 3,691 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (163% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01116882, a NA study, has completed, sponsored by Baim Institute for Clinical Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,691 participants
- Enrollment target
Study Summary
The primary objective of the trial is to compare the acute safety and long term outcomes between hospitals with cardiac surgery on-site (SOS hospitals) and hospitals without cardiac surgery on-site (non-SOS hospitals) for patients with ischemic heart disease treated with elective percutaneous coronary intervention (PCI) (stable angina, acute coronary syndrome, or non-Q wave MI) presenting to non-SOS hospitals.
Interventions
- PROCEDURE PCI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,691 participants |
| Start Date | 2006-06 |
| Est. Completion | 2012-12 |
| Phase | NA |
What the finished NCT01116882 record still lists
NCT01116882 is an interventional study that assigns participants to a tested intervention. Its 3,691 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (163% higher).
The record links to 0 conditions, and to 1 intervention - of which PCI is the first listed.
NCT01116882 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01116882 about?
NCT01116882 is a clinical study titled "Percutaneous Coronary Intervention (PCI) Outcomes in Community Versus Tertiary Settings". The primary objective of the trial is to compare the acute safety and long term outcomes between hospitals with cardiac surgery on-site (SOS hospitals) and hospitals without cardiac surgery on-site (non-SOS hospitals) for patients with ischemic heart disease treated with elective percutaneous corona...
What is the current status of trial NCT01116882?
This trial is currently completed. It is a NA study. The enrollment target is 3,691 participants. The study started on 2006-06. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01116882?
The interventions under investigation include: PCI (PROCEDURE).
Who is sponsoring clinical trial NCT01116882?
This trial is sponsored by Baim Institute for Clinical Research, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01116882's enrollment target sits among peer trials
3,691 36th of 2000 higher than 1,965 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06401863 · 3,691 participants · NA
Shared Decision for Drug Interactions in Oral Anticoagulation
- NCT06784960 · 3,689 participants · NA
Communication Strategies to Increase HPV Vaccination Intention
- NCT06058377 · 3,680 participants · Phase 3
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
- NCT06076304 · 3,720 participants · Phase 4
Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia